Skip to main content
Market Activity
CLOSE
Market Activity
Stocks
Funds + ETFs
Indexes
Commodities
Cryptocurrency
Currencies
Futures
Fixed Income
Global Markets
Quick Links
Real-Time Quotes
After-Hours Quotes
Pre-Market Quotes
Nasdaq-100
Symbol Screener
Online Brokers
Glossary
Sustainable Bond Network
Symbol Change History
IPO Performance
Ownership Search
Dividend History
Market Events
Economic Calendar
Earnings
IPO Calendar
Dividend Calendar
SPO Calendar
Holiday Calendar
Analyst Activity
Analyst Recommendations
Daily Earnings Surprise
Forecast Changes
Commodities
Gold
Copper
Crude Oil
Natural Gas
Nasdaq Data
Statistical Milestones
Total Returns
Daily Market Statistics
Most Active
See All Market Activity
News + Insights
CLOSE
Markets
Companies
Coronavirus
Technology
Personal Finance
Financial Advisors
Topics
Blockchain
Commodities
Cryptocurrencies
Earnings
Governance
IPOs
Retirement
Stocks
Features
World Reimagined
Smart Investing
Innovation Realized
Market Makers by Phil Mackintosh
TradeTalks
Nasdaq Watch
World Reimagined Podcast
See All News + Insights
Solutions
CLOSE
Raise & Access Capital
List with Nasdaq
Nasdaq Private Market
Private Fund Liquidity
Investor Relations Intelligence
Optimize Governance Practices
Board Portal Software
Board Assessments & Evaluations
Nasdaq Center for Board Excellence
ESG Reporting/Data Management
Corporate Services COVID-19 Center
Directors’ and Officers’ Questionnaires
Transform with Technology
Market Infrastructure Technology
Non-Traditional Exchanges & New Markets
Sell-Side Technology
Buy-Side Technology
Catastrophe Risk Modelling
Gain Market Intelligence
Buy-Side Intelligence
Investment Data & Analytics
Market Data & Feeds
Nasdaq Global Indexes
Institutional Capital with eVestment
Trade Global Markets
Equities
Equity Derivatives
ETFs & ETPs
Fixed Income
Commodities
Connectivity
Post Trade Services
Clearing
Exchange Oversight
Sustainable Bonds
See All Solutions
About
CLOSE
Our People
Careers
Press Center
Contact
Quick Links
Diversity, Inclusion and Belonging
Nasdaq Marketsite
Investor Relations
ESG Reporting Guide
European Markets
Nasdaq Nordic Foundation
Nasdaq Thought Leadership
Nasdaq Initiatives
Nasdaq Responds to Covid-19
TotalMarkets
Public Policy Advocacy
Sustainability at Nasdaq
Nasdaq Entrepreneurial Center
Nasdaq Ventures
Nasdaq and the Cloud
See All About
Log in
Data is currently not available
Data is currently not available
Find a Symbol
Search for Press Releases
When autocomplete results are available use up and down arrows to review and enter to select. Touch device users, explore by touch or with swipe gestures.
Edit my quotes
Stealth BioTherapeutics Corp. ADS
(MITO)
Nasdaq
Listed
Nasdaq
100
Data is currently not available
Add to Watchlist
Add to Portfolio
Quotes
Summary
Live
Real-Time
Live
After-Hours
Live
Pre-Market
Live
Charts
Live
NEWS & ANALYSIS
News
Live
Press Releases
Live
Analyst Research
Live
Dividend History
Historical Quotes
Historical NOCP
Financials
Earnings
P/E & PEG Ratios
Option Chain
Short Interest
Institutional Holdings
Insider Activity
SEC Filings
Revenue EPS
MITO
MITO PRESS RELEASES
MITO Press Releases
Published
Apr 6, 2021
Stealth BioTherapeutics Reports Fiscal Year 2020 Financial Results And Recent Business Highlights
Published
Apr 6, 2021
Published
Mar 31, 2021
Stealth BioTherapeutics to Report Full Year 2020 Financial Results on Tuesday, April 6, 2021
Published
Mar 31, 2021
Published
Mar 16, 2021
Stealth BioTherapeutics Announces Promotion of Marty Redmon to Chief Research & Development Officer
Published
Mar 16, 2021
Published
Mar 2, 2021
Stealth BioTherapeutics to Present at Upcoming Investor Conferences in March
Published
Mar 2, 2021
Published
Feb 23, 2021
Stealth BioTherapeutics Completes Enrollment of Phase 2 Study in Dry Age-Related Macular Degeneration with Geographic Atrophy
Published
Feb 23, 2021
Published
Feb 10, 2021
Stealth BioTherapeutics Announces Pricing Of $4.7 Million Registered Direct Offering Of American Depositary Shares
Published
Feb 10, 2021
Published
Jan 7, 2021
Stealth BioTherapeutics to Participate in Upcoming January Investor Conferences
Published
Jan 7, 2021
Published
Jan 5, 2021
Stealth BioTherapeutics Granted Pre-NDA Meeting For Elamipretide As A Treatment For Cardiomyopathy In Barth Syndrome
Published
Jan 5, 2021
Published
Dec 9, 2020
Stealth BioTherapeutics Announces Elamipretide Clinical Data to be Presented at the 13th International Conference on Cachexia, Sarcopenia and Wasting Diseases
Published
Dec 9, 2020
Published
Dec 7, 2020
Stealth BioTherapeutics Announces Appointment of Eve E. Slater, M.D., F.A.C.C. to its Board of Directors
Published
Dec 7, 2020
Published
Nov 24, 2020
Stealth BioTherapeutics Announces Closing of $3.2 Million Registered Direct Offering
Published
Nov 24, 2020
Published
Nov 20, 2020
Stealth BioTherapeutics Announces $3.2 Million Registered Direct Offering
Published
Nov 20, 2020
Published
Nov 5, 2020
Stealth BioTherapeutics Reports Third Quarter 2020 Financial Results And Recent Business Highlights
Published
Nov 5, 2020
Published
Nov 4, 2020
Stealth BioTherapeutics Announces Development Financing To Advance Elamipretide Clinical Trials
Published
Nov 4, 2020
Published
Oct 30, 2020
Stealth BioTherapeutics to Report Third Quarter 2020 Financial Results on Thursday, November 5, 2020
Published
Oct 30, 2020
Published
Oct 19, 2020
Stealth BioTherapeutics Announces Poster Presentation at American Society of Human Genetics (ASHG) Virtual Annual Meeting
Published
Oct 19, 2020
Published
Sep 23, 2020
Stealth BioTherapeutics Announces Poster Presentation at 2020 Annual NEALS Meeting
Published
Sep 23, 2020
Published
Sep 10, 2020
Stealth BioTherapeutics to Present at Upcoming Investor Conferences in September
Published
Sep 10, 2020
Published
Aug 6, 2020
Stealth BioTherapeutics Reports Second Quarter 2020 Financial Results and Recent Business Highlights
Published
Aug 6, 2020
Published
Jul 30, 2020
Stealth BioTherapeutics to Report Second Quarter 2020 Financial Results on Thursday, August 6, 2020
Published
Jul 30, 2020
...
Back to MITO Overview
Related Symbols
GME
Data is currently not available
AAPL
Data is currently not available
TSLA
Data is currently not available
AMC
Data is currently not available
My Quotes
My Quotes
Watchlist
Portfolio
Add/Edit Symbols
View as Table
Add symbols
now or see the quotes that matter to you, anywhere on Nasdaq.com. Start browsing
stocks
,
funds and ETFs
, and
more asset classes.
/
Add/Edit Symbols
Edit Watchlist
Your Watchlist is empty.
Add/Edit Symbols
Create your Watchlist to save your favorite quotes on Nasdaq.com.
Log in
or
create a free account
to get started.
/
Outsmart the market with Smart Portfolio analytical tools powered by TipRanks.
Go to Smart Portfolio
Back
Add a symbol to your watchlist
Most Active
Data is currently not available
Edit My Quotes
Add up to 25 symbols
To add symbols:
Type a symbol or company name. When the symbol you want to add appears, add it to My Quotes by selecting it and pressing Enter/Return.
Copy and paste multiple symbols separated by spaces.
These symbols will be available throughout the site during your session.
Save data
Data is currently not available
Your symbols have been updated
You'll now be able to see real-time price and activity for your symbols on the My Quotes of Nasdaq.com.
Continue
Data is currently not available
Edit Watchlist
Add up to 20 symbols
To add symbols:
Type a symbol or company name. When the symbol you want to add appears, add it to Watchlist by selecting it and pressing Enter/Return.
Copy and paste multiple symbols separated by spaces.
These symbols will be available throughout the site during your session.
Save data